Garrick Brown, MD. Digestive Health Specialists Tacoma Gig Harbor

Similar documents
Understanding Inflammatory Bowel Diseases (IBD):

Inflammatory Bowel Diseases

10/23/2014. Program Goals

This program is supported by an educational grant from Janssen Biotech Inc, and a sponsorship from Takeda.

This program is supported by an educational grant from Janssen Biotech Inc., Shire, Inc., and a sponsorship from Takeda

We will discuss: Inflammatory Bowel Diseases. Life With IBD. What Are the Potential Causes of IBD?

Understanding Inflammatory Bowel Diseases: What Every Patient Needs to Know

I B D. etter than this. isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES

Welcome to Week 2 of the Crohn s & Colitis Foundation of America (CCFA) Online Support Group.

Speaker Introduction

Inflammatory Bowel Disease

Understanding IBD Medications and Side Effects

How do I choose amongst medicines for inflammatory bowel disease. Maria T. Abreu, MD

Medical therapies and IBD

What Will This Talk Cover? 101: The Basics of Inflammatory Bowel Disease. Terms & Abbreviations. What Is Normal GI Anatomy?

The ABCs of Inflammatory Bowel Disease. Jennifer Choi, M.D. Associate Director March 31, 2012

Crohn s Disease. Resident Lecture 1/17/19

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC

Treatment Options. Suresh Pola, MD Kaiser San Diego

Regulatory Status FDA-approved indications: Entyvio is an α4β7integrin receptor antagonist indicated for: (1)

My Child Has Inflammatory Bowel Disease : Why? What now? What s next?

Treating Crohn s and Colitis in the ASC

Pharmacotherapy of Inflammatory Bowel Disorder

Understanding IBD Medications. and Side Effects

Pharmacotherapy of Inflammatory Bowel Disorder

INFLAMMATORY BOWEL DISEASE (IBD): CROHN S DISEASE

What is Inflammatory Bowel Disease (IBD)?

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine

INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments

INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments

Immune Modulating Drugs Prior Authorization Request Form

Carefirst.+.V Family of health care plans

Ulcerative Colitis. National Digestive Diseases Information Clearinghouse. What is ulcerative colitis (UC)?

INFLAMMATORY BOWEL DISEASE. Brittany Palasik, PharmD, BCPS University of North Texas System College of Pharmacy

Crohn's Disease. What causes Crohn s disease? What are the symptoms?

IBD Module 2: Medication and Patient Management. Kami Roake, PharmD Rheumatology & Gastroenterology Pharmacist University of Utah Hospitals & Clinics

Dr. Elmer Schabel, MD. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (No conflicts of interest)

The Medical Letter. on Drugs and Therapeutics. Sulfasalazine can cause reversible. therapy may be more effective Lialda (Shire)

What is Crohn's disease?

Drug Class Prior Authorization Criteria Therapeutic Agents in Rheumatic and Inflammatory Diseases

Facts THE CROHN S COLITIS. Living Well with IBD

Of Treatment For Inflammatory Bowel Diseases

Index. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type.

Living with Crohn s Disease

Pharmacotherapy of Inflammatory Bowel Disorder

Certain genes passed on from parent to child increase the risk of developing Crohn's disease, if the right trigger occurs.

CROHN S DISEASE. The term "inflammatory bowel disease" includes Crohn's disease and the other related condition called ulcerative colitis.

Living with Ulcerative Colitis

The Road to Remission

Outline. Biologic Drugs in Inflammatory Bowel Disease Dr. Jason Etzel MD The Vancouver Clinic. Biologic Drugs. Biologic Drugs. Biologic Drugs Anti-TNF

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Ixifi* (infliximabqbtx), Renflexis (infliximab-abda)

What is Crohn's disease?

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

Efficacy and Safety of Treatment for Pediatric IBD

New Perspectives on the Diagnosis and Management of IBD. Disclosures

Disclosure of Affiliations. The Way We Hope It Goes. Medicines and Surgery for IBD. None. Cases: Sweet and Not So Sweet

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

What is ulcerative colitis?

NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL

The National Association of Crohn s and Colitis of Trinidad and Tobago CROHN S DISEASE AND ULCERATIVE COLITIS GENERAL PATIENT INFORMATION

Stelara. Stelara (ustekinumab) Description

Slide 1 Medications in inflammatory bowel disease a primer for health care providers. Slide 2. Slide 3 Theory of pathogenesis. IBD - epidemiology

Regulatory Status FDA-approved indication: Humira and Amjevita are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3)

WHAT IS ULCERATIVE COLITIS?

Efficacy and Safety of Treatment for Pediatric IBD

Understanding Learning is the first step to getting help.

62 HUMIRA (ADALIMUMAB) 62 Forecast assumptions 66 Humira forecast Bibliography 70 LIALDA (MESALAZINE MMX) 71 Lialda forecast

Regulatory Status FDA-approved indication: Humira and Amjevita are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3)

Best Practices in the Diagnosis and Treatment of Inflammatory Bowel Disease

PIBD03 - Page 1 of June-03

Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children

Judith Collins, MD Assoc Professor of Gastroenterology & Hepatology Inflammatory Bowel Disease Program, OHSU

Living with Crohn s Disease

Regulatory Status FDA-approved indication: Humira and its biosimilars are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-5)

REGISTRATION FORM. Registration. Demographics. Date of Registration [e_assessdt] Birth Date (mm/yyyy) [birthdt] Date of Diagnosis: Day [diagday]

Inflammatory Bowel Disease Medical Exam Questionnaire

CLINICAL MEDICAL POLICY

Inflammatory Bowel Disease. Your Illness and Its Treatment

Clinical Policy: Vedolizumab (Entyvio) Reference Number: CP.PHAR.265 Effective Date: Last Review Date: Line of Business: Medicaid

INFLAMMATORY BOWEL DISEASE 101: Understanding Your Child s Diagnosis

PEDIATRIC INFLAMMATORY BOWEL DISEASE

Effective Health Care Program

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town

Best Practices in the Diagnosis and Treatment of Inflammatory Bowel Disease

Laurie S. Conklin, M.D. Inflammatory Bowel Disease Program Children s National Medical Center

IBD Medical Treatments 2018

Crohn s disease CONDITION GUIDE

Remicade (infliximab), Inflectra (infliximab-dyyb), Renflexis (infliximababda)

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health

COPYRIGHT. Inflammatory Bowel Disease What Every Clinician Needs to Know. Adam S. Cheifetz, MD. Director, Center for Inflammatory Bowel Disease

This information explains the advice about Crohn's disease that is set out in NICE guideline CG152.

Crohn s Disease. Questions & Answers

Medical Therapy for Pediatric IBD: Efficacy and Safety

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

1. Background: Infliximab is administered parenterally; therefore, it is not covered under retail pharmacy benefits.

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

Ali Keshavarzian MD Rush University Medical Center

Transcription:

Garrick Brown, MD Digestive Health Specialists Tacoma Gig Harbor

Today s Objectives Define IBD, its potential causes and diagnosis Discuss management and treatment Discuss complementary and alternative medicine Highlight special populations Review role of diet and nutrition in IBD Answer questions

What are Inflammatory Bowel Diseases? Inflammatory including Crohn s disease and ulcerative colitis 1.6 million Americans 70,000 new cases each year 1 in 200 people Symptoms, course of disease, and prognosis differ from one person to the next

Potential Factors to Consider Environmental Exposures Genetic Factors Gut Microbiota Immune System Abnormalities

Spectrum of IBD Crohn s Disease Patchy, full-thickness inflammation Mouth to anus involvement Extra-intestinal manifestations Ulcerative Colitis Continuous, superficial inflammation Colon and/or rectum Extra-intestinal manifestations Indeterminate Colitis 10%-15%

Diagnostic Process Crohn s disease Ulcerative colitis Medical History and Physical Examination Diagnostic testing, that may include Lab tests Imaging Endoscopy Other diagnosis

Recognizing Symptoms of IBD Flares Diarrhea Often increased from usual course of disease Rectal bleeding Abdominal pain or cramping Low-grade fever Fatigue

Understanding Complications of Crohn s Disease Obstruction Intestinal obstruction Abscess Fistula Stricture Colorectal cancer Fistula

Understanding Complications of Ulcerative Colitis Anemia from blood loss Perforation (rupture) of the bowel Colorectal cancer Toxic megacolon Perforation

Extra-Intestinal Manifestations Bones Arthritis of hands and feet, lower spine (e.g. Ankylosing Spondilitis) Kidneys Liver Oral ulceration Eye inflammation Skin sores (e.g. pyroderma ganrenosm, erythema nodosum)

Comprehensive IBD Management Minimize treatment toxicity Provide emotional support Prevent cancer Prevent/ Treat complications Reduce/ Eliminate inflammation IBD Management Goals Control symptoms Induce/ Maintain remission Improve quality of life Ensure adequate nutrition

Understanding Treatment Options Prescription medications Over-the-counter agents Complementary and alternative therapies Surgery

Prescription Medications Class Aminosalicylates Corticosteroids Agents Balsalazide (Colazal, GIAZO ) Mesalamine formulations Lialda Apriso Asacol HD Rowasa Delzicol Canasa Pentasa Olsalazine (Dipentum ); Sulfasalazine (Azulfidine ) Budesonide (Entocort, UCERIS ) Methylprednisolone (Medrol ) Prednisone Prednisolone Antibiotics Ciprofloxacin (Cipro, Proquin ) Metronidazole (Flagyl ) Rifaximin (Xifaxan )

Prescription Medications Class Immunomodulators Agents Azathioprine (Imuran, Azasan ) Cyclosporine (Neoral ) 6-Mercaptopurine (Purinethol ) Methotrexate Tacrolimus (Prograf ) Biologic therapies Anti-TNF antibodies Adalimumab (Humira ) Certolizumab pegol (Cimzia ) Infliximab (Remicade ) Golimumab (Simponi ) Integrin Antagonist Receptors Natalizumab (Tysabri ) Vedolizumab (Entyvio TM ) Interleukin-12 and 23 Antagonist Ustekinumab (Stelarai )

Biosimilars Products that are highly similar to but not exact copies of biologic medicines Inflectra TM (infliximab-dyyb) has biosimilarity to Remicade (infliximab) Anti-TNF for treatment of Crohn s disease (in adults and children) and ulcerative colitis (in adults) Amjevita TM (adalimumab-atto), has biosimilarity to Humira (adalimumab), Anti-TNF for treatment of Crohn s disease and ulcerative colitis Source: http://www.fda.gov/newsevents/newsroom/pressannounceme nts/ucm494227.htm - accessed 4/13/16

Over-the-Counter (OTC) Agents Address only specific symptoms Antidiarrheal agents Laxatives Pain relievers Important to discuss with physician before taking any OTC medications

Types of Surgery in IBD Crohn s Disease Strictureplasty Gastrojejunostomy (upper GI) Short bowel resection Partial colectomy Proctocolectomy with end ileostomy Perianal surgery Intestinal transplantation Ulcerative Colitis Proctocolectomy (removal of the colon and rectum) With end ileostomy Restorative (ileoanal anastomosis or J pouch)

Complementary and Alternative Medicine What is complementary and alternative medicine (CAM)? Group of diverse medical and healthcare systems, practices and products not presently part of conventional medicine 1 Examples» Natural products (supplements, vitamins, probiotics» Mind and body medicine (meditation, acupuncture, yoga)» Massage Lack strong scientific evidence on benefits in treating inflammatory bowel diseases Not FDA-regulated Important to seek out good data to minimize potential risk Should complement, not replace, traditional therapies Tell your doctor everything you are taking 1. NCCAM publication # D347.

Understanding IBD in Children & Adolescents Special considerations Ability to swallow capsules or tablets Side effects of drug therapy Risks of long-term corticosteroid use Emotional/social concerns Adherence Growth failure and need for nutritional supplementation Emotional well-being

Understanding IBD in Pregnant Women Special considerations IBD should be controlled before considering pregnancy Remain on most prescribed medications Well-balanced diet with vitamins, including folic acid Ongoing communication between obstetrician and gastroenterologist

Understanding the Importance of Diet & Nutrition in Managing IBD Causes of nutritional deficits Decreased intake (no desire to eat) Active disease Protein and fluid loss Decreased absorption of nutrients (when small intestine is affected by CD) Fat Vitamins

Understanding the Importance of Diet & Nutrition in Managing IBD Create a food journal Eliminate problematic foods Strive for a well-balanced, healthy diet based on Hydration Electrolyte balance Continual adequate nutrient intake

IBD Research Genetics Several genes linked to both CD and UC Large genome-wide studies continue Biologic markers Measurable substances that may help characterize disease Clinical trials Better understand disease Develop novel therapies

Participate in Partners Participate in groundbreaking research Propose, discuss, and vote on research questions and topics Connect your mobile health apps to better manage your disease www.ccfapartners.org

Don t Forget Clinical Trials! Clinical trials are well-organized studies that evaluate a treatment s efficacy and safety. Patients can make informed decisions to participate in a clinical trial for IBD treatment. www.researchmatch.org/partner/ccfa www.clinicaltrials.gov www.ccfa.org/resources/clinical-trials-101

Living Well With IBD Be compliant with medications Understand your disease and possible complications Schedule follow-up appointments Maintain a well-balanced diet Establish a support system Empower yourself with information

Crohn s & Colitis Foundation Resources Irwin M. and Suzanne R. Rosenthal IBD Help Center M-F, 9:00 AM-5:00 PM ET Phone: 1-888-694-8872 Email: info@crohnscolitisfoundation.org Brochures and factsheets: online.ccfa.org/brochures Educational webcasts: www.ccfa.org/resources/webcasts.html

Crohn s & Colitis Foundation Resources Connect with other patients Crohn s & Colitis Community website: ccfacommunity.org Support groups and Power of Two (peer mentors): http://www.crohnscolitisfoundation.org /living-with-crohns-colitis /find-a-support-group/ GI Buddy: online tracking tool and mobile app www.gibuddy.org New Teen Website: www.justlikemeibd.org

Questions & Answers